18.03.2020 15:13:17
|
Stock Alert: IMV Up 32%; Plans To Develop Vaccine Against Covid-19
(RTTNews) - Shares of IMV Inc. (IMV) are currently up 32% after the thinly-traded pharma company announced plans to develop a COVID-19 vaccine based on its lipid-based delivery platform called DPX.
The clinical-stage biopharmaceutical company said it is advancing the clinical development of a DPX-based vaccine candidate against COVID-19.
The company believes that this peptide-based approach, together with the portability of the DPX platform, offers the possibility of accelerated development and rapid, large-scale production of a vaccine.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IMV Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |